City of Hope, a NCI-designated Comprehensive Cancer Center
Skip Navigation
Project 1--Evaluation of safety and correlative immunogenicity studies of CMVPepVax co-injected with PF03512676 adjuvant in recipients of allogeneic stem cell transplant Project 2--CMVPepVax to protect stem cell transplant recipients from Cytomegalovirus infection-University of Minnesota collaborative study Project 3--Control of CMV infection in allogeneic stem cell transplant recipients using attenuated MVA-based CMV subunit vaccine Project 4--A Phase I study of a p53-MVA vaccine for advanced colon, gastric and pancreatic cancer Project 5--HCMV vaccine Produced from BAC-MVA that blocks epithelial and fibroblast entry Project 6--Evaluation of protective CMV vaccines in rhesus macaques Project 7--IDO-silencing Salmonella therapy for the treatment of primary and metastatic PDAC Project 8--WT1 as a biomarker to predict relapse in patients with acute leukemia and MDS
Project 9--Optimizing shRNA approaches for control of Lymphoma using Salmonella delivery systems